Helen Y.

Helen Y. has been working in the medical field since 2011. Helen began as an Intern in Clinical Medicine at the First Affiliated Hospital, Sun Yat-sen University in 2011, then moved on to become a Resident of Oncology at the Shanghai Cancer Hospital, Fudan University in 2013. In 2017, Helen Y. joined BeiGene as a Physician, then was promoted to Sr. Physician. Most recently, they began working as a Medical Director at Immune-Onc Therapeutics in 2022.

Helen Y. has a MD, PhD in Oncology from Fudan University and a Bachelor of Medicine in Clinical Medicine from Sun Yat-sen University. Helen also holds a Chinese Medical Practitioner Certification from the National Health and Family Planning Commission of the People's Republic of China, which they obtained in December 2013.